Search Results - "Ferreira, Vinicius L"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis by Lucchetta, Rosa C., Tonin, Fernanda S., Borba, Helena H. L., Leonart, Letícia P., Ferreira, Vinicius L., Bonetti, Aline F., Riveros, Bruno S., Becker, Jefferson, Pontarolo, Roberto, Fernandez-Llimós, Fernando, Wiens, Astrid

    Published in CNS drugs (01-09-2018)
    “…Background A broad range of disease-modifying therapies (DMTs) for relapsing–remitting multiple sclerosis (RRMS) is available. However, the efficacy and safety…”
    Get full text
    Journal Article
  2. 2

    Lag times in the publication of network meta-analyses: a survey by Tonin, Fernanda S, Araujo, Ariane G, Fachi, Mariana M, Ferreira, Vinicius L, Pontarolo, Roberto, Fernandez-Llimos, Fernando

    Published in BMJ open (06-09-2021)
    “…ObjectiveWe assessed the extent of lag times in the publication and indexing of network meta-analyses (NMAs).Study designThis was a survey of published NMAs on…”
    Get full text
    Journal Article
  3. 3

    Cross-Cultural Translation into Brazilian Portuguese and Validation of the Oral Anticoagulation Knowledge Tool (AKT-Br) by Mainka, Felipe F, Ferreira, Vinicius L, Mendes, Antonio M, Marques, Gustavo L, Correr, Cassyano J, Tonin, Fernanda S, Pontarolo, Roberto

    “…Oral anticoagulants are the treatment of choice for diverse types of coagulation disorders. Warfarin is widely used by the Brazilian population, possibly due…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies by Ferreira, Vinicius L., Mainka, Felipe F., Wiens, Astrid, Pontarolo, Roberto

    Published in Clinical drug investigation (01-09-2023)
    “…Background and Objective Migraine is a neurological disorder characterized by episodes of moderate-to-severe headache. The emergence of drugs derived from…”
    Get full text
    Journal Article
  6. 6

    Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies by Leonart, Letícia P., Tonin, Fernanda S., Ferreira, Vinicius L., Fernandez-Llimos, Fernando, Pontarolo, Roberto

    Published in Endocrine (01-01-2019)
    “…Purpose Acromegaly is a rare disease that often requires drug treatment to achieve control, with pegvisomant being one of the most widely used therapies. In…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Medical Treatments for Acromegaly: A Systematic Review and Network Meta-Analysis by Leonart, Letícia P., Ferreira, Vinicius L., Tonin, Fernanda S., Fernandez-Llimos, Fernando, Pontarolo, Roberto

    Published in Value in health (01-07-2018)
    “…Acromegaly results from the hypersecretion of growth hormone. Because of the low incidence rates of this disease worldwide, few clinical trials evaluating drug…”
    Get full text
    Journal Article
  10. 10

    Cost-effectiveness of acromegaly treatments: a systematic review by Leonart, Letícia P., Borba, Helena H. L., Ferreira, Vinicius L., Riveros, Bruno S., Pontarolo, Roberto

    Published in Pituitary (01-12-2018)
    “…Purpose Acromegaly is a rare disease that results in the enlargement of body extremities and in organomegaly. Treatments include surgery, drugs, and…”
    Get full text
    Journal Article
  11. 11

    Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta‐analysis by Ferreira, Vinicius L, Assis Jarek, Nayara A, Tonin, Fernanda S, Borba, Helena H L, Wiens, Astrid, Muzzillo, Dominique A, Pontarolo, Roberto

    Published in Journal of gastroenterology and hepatology (01-04-2017)
    “…Background and Aim Ledipasvir with sofosbuvir (LED/SOF) for the treatment of patients infected with genotype 1 hepatitis C virus can be used with or without…”
    Get full text
    Journal Article
  12. 12

    Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials by Ferreira, Vinicius L., Tonin, Fernanda S., Assis Jarek, Nayara A., Ramires, Yohanna, Pontarolo, Roberto

    Published in Clinical drug investigation (01-07-2017)
    “…Background and Objectives Second-generation direct-acting antivirals (DAAs) have recently arisen as more effective and safer treatments for chronic hepatitis…”
    Get full text
    Journal Article
  13. 13

    Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies by Della Rocca, Ana M., Leonart, Letícia P., Ferreira, Vinicius L., Tonin, Fernanda S., Steffenello-Durigon, Giovanna, Del Moral, Joanita A.G., Fernandez-Llimos, Fernando, Pontarolo, Roberto

    Published in Clinical lymphoma, myeloma and leukemia (01-08-2021)
    “…Burkitt lymphoma (BL) is an aggressive hematologic cancer. This study synthetized the evidence about the efficacy and safety of chemotherapy treatments used in…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Impact of pivoting bite tip on bite force measurement tests by Santiago, Orlando, Cruz, Rosana C., da Cunha, Thiago Henrique R., Lacerda, Rodrigo G., Ferreira, Marcus Vinícius L., Huebner, Rudolf

    Published in Clinical oral investigations (01-06-2023)
    “…Objective Present a gnathodynamometer design that increases patient comfort, precision, and/or ease for the operator during bite force tests. Materials and…”
    Get full text
    Journal Article